PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway

被引:111
作者
Tang, Shi-Lin [1 ,2 ]
Chen, Wu-Jun [1 ,3 ]
Yin, Kai [1 ]
Zhao, Guo-Jun [1 ]
Mo, Zhong-Cheng [1 ]
Lv, Yun-Cheng [1 ]
Ouyang, Xin-Ping [1 ]
Yu, Xiao-Hua [1 ]
Kuang, Huai-Jun [1 ,4 ]
Jiang, Zhi-Sheng [1 ]
Fu, Yu-Chang [5 ]
Tang, Chao-Ke [1 ]
机构
[1] Univ S China, Inst Cardiovasc Res, Key Lab Atherosclerol Hunan Prov, Life Sci Res Ctr, Hengyang 421001, Hunan, Peoples R China
[2] Univ S China, Affiliated Hosp 1, Dept Intens Care Unit, Hengyang 421001, Hunan, Peoples R China
[3] Univ S China, Inst Pharm & Pharmacol, Hengyang 421001, Hunan, Peoples R China
[4] Univ S China, Affiliated Hosp 2, Dept Cardiovasc Med, Hengyang 421001, Hunan, Peoples R China
[5] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA
关键词
PAPP A; IGF-1/PI3-K/Akt signaling pathway; ABCA1; ABCG1; SR-BI; LXR alpha; Atherosclerosis; PLASMA-PROTEIN-A; NF-KAPPA-B; GROWTH-FACTOR-I; SMOOTH-MUSCLE-CELLS; CASSETTE TRANSPORTER A1; LIVER X RECEPTOR; CORONARY-ARTERY; SR-BI; PROTEOLYTIC ACTIVITY; LIPID-ACCUMULATION;
D O I
10.1016/j.atherosclerosis.2012.03.005
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Pregnancy-associated plasma protein-A (PAPP-A) has been involved in the atherosclerotic process through regulation of local expression of IGF-1 that mediates the activation of the phosphatidylinositol-3 (PI3-K) and Akt kinase (Akt) signaling cascades which lead to constitutive nitric oxide formation, with its attending vasodilator, antiplatelet and insulin-sensitizing actions. In addition, IGF-1 may decreased cholesterol efflux through reductions of expression in ABCA1 and SR-B1 by the PI3-K/Akt signaling pathway. In the current study, we examined whether PAPP-A was involved in LXR alpha regulation and in expression of ABCA1, ABCG1 or SR-B1 through the IGF-I-mediated signaling pathway (IGF/PI3-K/Akt). Results showed that PAPP-A significantly decreased expression of ABCA1, ABCG1 and SR-BI at both transcriptional and translational levels in a dose-dependent and time-dependent manner. Cellular cholesterol content was increased while cholesterol efflux was decreased by PAPP-A treatment. Moreover, LXR alpha which can regulate the expression of ABCA1, ABCG1 and SR-B1, was also down-regulated by PAPP-A treatment. LXR alpha-specific activation by LXR alpha agonist almost rescued the down-regulation of ABCA1, ABCG1 and SR-B1 expression by PAPP-A. In addition, PAPP-A can induce the IGF-1/PI3-K/Akt pathway in macrophages. Furthermore, our results indicate that the decreased levels observed in LXR alpha, ABCA1, ABCG1 and SR-B1 mRNA and protein levels upon treating cells with PAPP-A were strongly impaired with the PI3-K inhibitors or IGF-1R siRNA while the MAPK cascade inhibitor did not execute this effect, indicating that the process of ABCA1, ABCG1 and SR-BI degradation by PAPP-A involves the IGF-1/PI3-K/Akt pathway. In conclusion, PAPP-A may first down-regulate expression of LXR alpha through the IGF-1/PI3-K/Akt signaling pathway and then decrease expression of ABCA1, ABCG1, SR-B1 and cholesterol efflux in THP-1 macrophage-derived foam cells. Therefore, our study provided one of the mechanisms for understanding the critical effect of PAPP-A in pathogenesis of atherosclerosis. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:344 / 354
页数:11
相关论文
共 69 条
[1]
The roles of different pathways in the release of cholesterol from macrophages [J].
Adorni, Maria Pia ;
Zimetti, Francesca ;
Billheimer, Jeffrey T. ;
Wang, Nan ;
Rader, Daniel J. ;
Phillips, Michael C. ;
Rothblat, George H. .
JOURNAL OF LIPID RESEARCH, 2007, 48 (11) :2453-2462
[2]
Role of PAPP-A in atherothrombosis: Messages to take home [J].
Andreotti, Felicita ;
Rio, Teresa ;
Conti, Elena .
ATHEROSCLEROSIS, 2009, 203 (02) :353-354
[3]
Effect of Bariatric Surgery-Induced Weight Loss on SR-BI-, ABCG1-, and ABCA1-Mediated Cellular Cholesterol Efflux in Obese Women [J].
Aron-Wisnewsky, Judith ;
Julia, Zelie ;
Poitou, Christine ;
Bouillot, Jean-Luc ;
Basdevant, Arnaud ;
Chapman, M. John ;
Clement, Karine ;
Guerin, Maryse .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :1151-1159
[4]
Pregnancy-associated plasma protein a as a marker of acute coronary syndromes [J].
Bayes-Genis, A ;
Conover, CA ;
Overgaard, MT ;
Bailey, KR ;
Christiansen, M ;
Holmes, DR ;
Virmani, R ;
Oxvig, C ;
Schwartz, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1022-1029
[5]
Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty [J].
Bayes-Genis, A ;
Schwartz, RS ;
Lewis, DA ;
Overgaard, MT ;
Christiansen, M ;
Oxvig, C ;
Ashai, K ;
Holmes, DR ;
Conover, CA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (03) :335-341
[6]
IGF-1 induces rat glomerular mesangial cells to accumulate triglyceride [J].
Berfield, AK ;
Chait, A ;
Oram, JF ;
Zager, RA ;
Johnson, AC ;
Abrass, CK .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (01) :F138-F147
[7]
Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin [J].
Boldt, HB ;
Overgaard, MT ;
Laursen, LS ;
Weyer, K ;
Sottrup-Jensen, L ;
Oxvig, C .
BIOCHEMICAL JOURNAL, 2001, 358 (02) :359-367
[8]
Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogeneic activity of IGF by degrading IGPBP-4 in vitro [J].
Byun, DW ;
Mohan, S ;
Yoo, M ;
Sexton, C ;
Baylink, DJ ;
Qin, XZ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :847-854
[9]
Lipopolysaccharide Down-regulates ABCA1 Expression in Foam Cells in a Nucleus Factor-κB Pathway-dependent Manner [J].
Cao Dong-Li ;
Yin Kai ;
Mo Zhong-Cheng ;
Hao Xin-Rui ;
Hu Yan-Wei ;
Li Xiao-Xu ;
Tang Ya-Ling ;
Tang Chao-Ke .
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2010, 37 (05) :540-548
[10]
Insulin-like growth factor-i regulation of hepatic scavenger receptor class BI [J].
Cao, WM ;
Murao, K ;
Imachi, H ;
Yu, X ;
Dobashi, H ;
Yoshida, K ;
Muraoka, T ;
Kotsuna, N ;
Nagao, S ;
Wong, NCW ;
Ishida, T .
ENDOCRINOLOGY, 2004, 145 (12) :5540-5547